Hamid Khoja
Tracked across 2 events · 17 articles · First seen Apr 10, 2026 · Last active Jun 16, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Hamid Khoja is the Chief Scientific Officer of FibroBiologics. His comments emphasize the reproducibility of the manufacturing platform and the foundational nature of the trial data, supporting the company's operational and scientific capabilities.
Jun 03, 2026 · 11 articles
Tech
Impact: Hamid Khoja, Chief Scientific Officer of FibroBiologics, commented on the significance of the preclinical data, highlighting the versatility of fibroblasts and the potential applications of the organoid platform.
Apr 10, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Hamid Khoja live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard